Cargando…
Correction of the hypomorphic Gabra2 splice site variant in mouse strain C57BL/6J modifies the severity of Scn8a encephalopathy
De novo gain-of-function mutations of SCN8A are a significant cause of developmental and epileptic encephalopathy (DEE) (MIM: 614558). The severely affected individuals exhibit refractory seizures, developmental delay, and cognitive disabilities, often accompanied by impaired movement. Individuals w...
Autores principales: | Yu, Wenxi, Mulligan, Megan K., Williams, Robert W., Meisler, Miriam H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756487/ https://www.ncbi.nlm.nih.gov/pubmed/35047853 http://dx.doi.org/10.1016/j.xhgg.2021.100064 |
Ejemplares similares
-
Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse*
por: Yu, Wenxi, et al.
Publicado: (2020) -
Recurrent and Non-Recurrent Mutations of SCN8A in Epileptic Encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015) -
Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
por: Lenk, Guy M., et al.
Publicado: (2020) -
Gabra2 is a genetic modifier of Dravet syndrome in mice
por: Hawkins, Nicole A., et al.
Publicado: (2021) -
C57BL/6J and C57BL/6N substrains differentially influence phenotype severity in the Scn1a
(+/−) mouse model of Dravet syndrome
por: Kang, Seok K., et al.
Publicado: (2018)